A pregnancy-specific multi-system disorder with unpredictable, variable and widespread manifestations
Aetiology
Risk factors
- Parity (more likely in first pregnancy)
- Molar pregnancy/triploidy
- Mutiparous women develop more severe disease
- Pre-existing conditions
- Pre-existing renal disease
- Pre-existing hypertension
- Diabetes
- Connective tissue disease
- Thrombophilias
Pathophysiology
- Diffuse vascular endothelial dysfunction with widespread circulatory disturbance
- Classified as early or late
- Early: <34 weeks, uncommon, associated with placental dysfunction
- Late: ≳34 weeks, accounds for ~9/10 cases
- Stage 1 - abnormal placental perfusion (placental ischaemia)
- Stage 2 - maternal syndrome (an anti-angiogenic state associated with endothelial dysfunction)
Liver disease
- HELLP syndrome - Haemolysis, Elevated Liver enzymes, Low PLatelets
Placental disease
Clinical presentation
- Hypertension, proteinuria and oedema
- Women may be asymptomatic at the time of their first presentation
Symptoms
- Rapidly progressive oedema
Signs
- Hyper-reflexia/involuntary movements/clonus
- Intra-uterine fetal death
Investigations
- Bloods: U+Es, serum urate, LFTs, FBC, coag screen
- Urine - protein creatinine ratio
Management
- Low dose aspirin (150 mg) - may be more beneficial in preventing severe early onset pre-eclampsia
- Used for high risk women
- Safe in pregnancy
- Commence before 16 weeks
- The only 'cure' for pre-eclampsia is birth
- Mother must be stabilised before birth
- Consider expectant management if pre-term
- Steriods/magnesium sulphate
- Most women delivered within 2 weeks of diagnosis
Complications
- HELLP syndrome (Hemolysis, Elevated Liver enzymes and Low Platelets)
- Disseminated intravascular coagulation (DIC)